Internal Medicine · Albany, GA
NPI
1205822657
Since 2005
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
2002 Palmyra Rd, Suite 101
Albany, GA, 31701
Phone (229) 889-9367
Groups this clinician bills Medicare through
Medicare paid, 2024
$113K
7,285 services
Medicare patients, 2024
235
Average age 74
Drug cost, 2024
$1.8M
14,630 prescriptions
Company payments, 2025
$2,039
From 23 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Devell R Young was code J1010 (injection, methylprednisolone acetate, 1 mg), 2,280 times for 21 patients. In total Devell R Young billed 7,285 services in 84 codes, and Medicare paid $113K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-01-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 2,280 | 21 | $0.10 | $221 |
| 99214 Office E&M - Established | Office | 505 | 218 | $69.28 | $35K |
| 36415 Venipuncture Blood Collection | Office | 448 | 207 | $8.37 | $3,752 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 396 | 192 | $10.99 | $4,352 |
| 85025 Blood Count | Office | 393 | 200 | $7.44 | $2,924 |
| 80053 Clinical Chemistry | Office | 388 | 197 | $10.28 | $3,988 |
| 80061 Clinical Chemistry | Office | 310 | 185 | $12.64 | $3,918 |
| 82043 Clinical Chemistry | Office | 285 | 165 | $5.60 | $1,597 |
| 82570 Clinical Chemistry | Office | 284 | 165 | $4.98 | $1,414 |
| 81003 Clinical Chemistry | Office | 267 | 162 | $2.14 | $571 |
| 83036 Blood Count | Office | 253 | 135 | $9.11 | $2,306 |
| 84443 Clinical Chemistry | Office | 193 | 149 | $16.24 | $3,133 |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 166 | 166 | $17.10 | $2,839 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 163 | 163 | $119.98 | $20K |
| 99213 Office E&M - Established | Office | 121 | 81 | $57.41 | $6,947 |
By year: 2022 $137K for 5,396 services; 2023 $117K for 4,821 services; 2024 $113K for 7,285 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 448 | 207 | $8.37 | $3,752 |
| 85025 Blood Count | 393 | 200 | $7.44 | $2,924 |
| 80053 Clinical Chemistry | 388 | 197 | $10.28 | $3,988 |
| 80061 Clinical Chemistry | 310 | 185 | $12.64 | $3,918 |
| 82043 Clinical Chemistry | 285 | 165 | $5.60 | $1,597 |
| 82570 Clinical Chemistry | 284 | 165 | $4.98 | $1,414 |
| 81003 Clinical Chemistry | 267 | 162 | $2.14 | $571 |
| 83036 Blood Count | 253 | 135 | $9.11 | $2,306 |
| 84443 Clinical Chemistry | 193 | 149 | $16.24 | $3,133 |
| 84550 Clinical Chemistry | 93 | 87 | $4.22 | $392 |
Medicare prescription drug claims, 2024
In 2024, the drug Devell R Young prescribed most often to Medicare patients was Amlodipine Besylate, with 910 prescriptions and refills. In total Devell R Young wrote 14,630 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 910 | 2,531 | 251 | $5,010 |
| Atorvastatin Calcium Generic | 897 | 2,556 | 267 | $10K |
| Carvedilol Generic | 466 | 1,262 | 136 | $4,858 |
| Losartan Potassium Generic | 406 | 1,139 | 116 | $4,414 |
| Valsartan Generic | 399 | 1,014 | 106 | $11K |
| Pravastatin Sodium Generic | 324 | 927 | 95 | $4,454 |
| Amlodipine-Valsartan Amlodipine Besylate/Valsartan | 299 | 804 | 81 | $18K |
| Nifedipine Er Nifedipine | 282 | 682 | 64 | $8,493 |
| Jardiance Empagliflozin | 272 | 507 | 64 | $301K |
| Metformin Hcl Generic | 236 | 653 | 74 | $1,264 |
| Gabapentin Generic | 229 | 507 | 79 | $3,664 |
| Tizanidine Hcl Generic | 224 | 404 | 97 | $1,783 |
| Levothyroxine Sodium Generic | 215 | 621 | 60 | $2,531 |
| Famotidine Generic | 209 | 525 | 79 | $2,225 |
| Tamsulosin Hcl Generic | 183 | 529 | 56 | $2,613 |
Brand drugs: 2,282 claims; generic drugs: 12,222 claims; opioid claims: 202.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Devell R Young $2,039 ($2,039 in general payments such as food, travel and fees) from 23 companies. The largest payer was Novo Nordisk Inc with $392.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 17 | $392 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 9 | $221 |
| AstraZeneca Pharmaceuticals LP AZN | 9 | $220 |
| Dexcom, Inc. DXCM | 10 | $157 |
| Amgen Inc. AMGN | 11 | $155 |
| GlaxoSmithKline, LLC. GSK | 10 | $142 |
| Lilly USA, LLC LLY | 10 | $126 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 6 | $114 |
| Sumitomo Pharma America, Inc. 4506.T | 6 | $98.67 |
| Pfizer Inc. PFE | 5 | $82.99 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.